UGT8 Antikörper (AA 366-393)
-
- Target Alle UGT8 Antikörper anzeigen
- UGT8 (UDP Glycosyltransferase 8 (UGT8))
-
Bindungsspezifität
- AA 366-393
-
Reaktivität
- Human, Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser UGT8 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Homologie
- Rat
- Aufreinigung
- This antibody is purified through a protein A column, followed by peptide affinity purification.
- Immunogen
- This UGT8 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 366-393 amino acids from the Central region of human UGT8.
- Klon
- RB29672
- Isotyp
- Ig Fraction
-
-
- Applikationshinweise
- WB: 1:1000. WB: 1:1000. IHC-P: 1:10~50
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.
- Haltbarkeit
- 6 months
-
-
The miR-30 Family Inhibits Pulmonary Vascular Hyperpermeability in the Premetastatic Phase by Direct Targeting of Skp2." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 21, Issue 13, pp. 3071-80, (2015) (PubMed).
: "
-
The miR-30 Family Inhibits Pulmonary Vascular Hyperpermeability in the Premetastatic Phase by Direct Targeting of Skp2." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 21, Issue 13, pp. 3071-80, (2015) (PubMed).
-
- Target
- UGT8 (UDP Glycosyltransferase 8 (UGT8))
- Andere Bezeichnung
- UGT8 (UGT8 Produkte)
- Synonyme
- Xlcgt antikoerper, cgt antikoerper, ugt4 antikoerper, AI850488 antikoerper, AW455908 antikoerper, Cgt antikoerper, Ugt8 antikoerper, mCerGT antikoerper, CGT antikoerper, UGT4 antikoerper, Ugt8a antikoerper, UDP glycosyltransferase 8 antikoerper, UDP galactosyltransferase 8A antikoerper, UGT8 antikoerper, ugt8 antikoerper, Ugt8a antikoerper, Ugt8 antikoerper
- Hintergrund
- Galactocerebrosides are abundant sphingolipids of the myelin membrane of the central nervous system and peripheral nervous system and are also present in small amounts in kidney. The key enzymatic step in the biosynthesis of galactocerebrosides consists of the transfer of galactose to ceramide catalyzed by UDP-galactose ceramide galactosyltransferase (CGT, EC 2.4.1.45). The enzyme encoded by the CGT gene is the first involved in complex lipid biosynthesis in the myelinating oligodendrocyte.[supplied by OMIM].
- Molekulargewicht
- 61438
- Gen-ID
- 7368
- NCBI Accession
- NP_001121646, NP_003351
- UniProt
- Q16880
- Pathways
- Cell-Cell Junction Organization
-